Boissel N, Huguet F, Leguay TT, Hunault M, et al. Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST Study. Blood 2026 Apr 24:blood.2026033309. doi: 10.1182/blood.2026033309.
PMID: 42126414